News Introducing the Sunday Times Tech 100: Life sciences part 2 In our second of three reports on the 2026 Sunday Times Tech 100, we focus on the first nine of 18 life sciences companies in the hardware category.
News Vanda bats away unwanted Cycle, Future Pak takeover bids Vanda Pharmaceuticals' board is unimpressed with takeover offers from both Cycle Pharma and Future Pak, saying they both “substantially undervalue” the company.
News Cycle Pharma makes $466m takeover bid for Vanda UK group Cycle Pharma has made an unsolicited takeover bid to buy Vanda Pharma of the US, which is already fending off an overture from Future Pak.
News TransThera's resistant biliary cancer drug cleared in China TransThera's Yochanra has been cleared in China as the world's first drug that can overcome resistance to FGFR inhibitors in cholangiocarcinoma.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.